IKT
Inhibikase Therapeutics Inc
2.20$
-6.9%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | +75.0% | +898.2% | -98.7% | +38,543.6% | +187.3% | -41.3% | -41.8% | +579.7% | +83.8% | |
| – | +147.1% | +531.9% | -97.2% | +41,681.5% | +187.3% | -42.6% | -41.7% | +592.8% | +82.9% | |
| – | +38.5% | +2,177.6% | -95.1% | +75,500.1% | +192.0% | -82.4% | +27.5% | +516.4% | +146.4% | |
| – | +38.5% | +2,177.6% | -95.1% | +75,500.1% | +192.0% | -43.4% | -42.5% | +636.1% | +83.3% | |
| – | +170.3% | +161.6% | – | – | – | -63.8% | +0.0% | – | – | |
| – | – | – | – | – | – | +944.5% | +0.0% | – | – | |
| – | +14.0% | +110.0% | +24.9% | +10.4% | -18.9% | -3.8% | -9.5% | +5.8% | +122.3% | |
| – | +14.0% | +110.0% | +17.3% | +11.0% | -14.1% | -8.9% | -7.0% | +8.6% | +122.3% | |
| – | +39.8% | -49.2% | -57.9% | -56.8% | +485.2% | -41.4% | +264.7% | -79.2% | – | |
| – | -18.1% | +169.9% | +5.0% | +71.8% | -36.7% | +5.6% | -43.8% | +45.8% | +22.8% | |
| – | – | – | – | +0.4% | – | – | – | – | – | |
| – | – | – | – | – | +292.6% | -45.2% | -47.8% | +764.2% | +82.3% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | +32.4% | -22.4% | +28.8% | -2.6% | +81.2% | +38.5% | +26.9% | +344.6% | +314.6% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.